Site Listing

Please choose the site that is most convenient for you

Study Name: A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Imatinib in Patients With Gastro-Intestinal Stromal Tumour in First Line
7 locations found